Pfizer Inc financial data

Symbol
PFE on NYSE
Industry
Pharmaceutical Preparations
Location
66 Hudson Boulevard East, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 102 % -36.4%
Quick Ratio 26.3 % -1.75%
Debt-to-equity 141 % +15.8%
Return On Equity 8.88 % +305%
Return On Assets 3.69 % +273%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.67B shares +0.01%
Entity Public Float 158B USD -23.7%
Common Stock, Value, Issued 480M USD +0.42%
Weighted Average Number of Shares Outstanding, Basic 5.66B shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 5.7B shares -0.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 63.6B USD +6.84%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.02B USD +658%
Income Tax Expense (Benefit) -28M USD +97.5%
Net Income (Loss) Attributable to Parent 8.03B USD +279%
Earnings Per Share, Basic 1.42 USD/shares +274%
Earnings Per Share, Diluted 1.41 USD/shares +281%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.04B USD -63.4%
Accounts Receivable, after Allowance for Credit Loss, Current 11.5B USD -0.89%
Inventory, Net 10.9B USD +6.5%
Other Assets, Current 4.25B USD -13.4%
Assets, Current 50.4B USD +16.2%
Other Long-term Investments 2.01B USD -46.1%
Property, Plant and Equipment, Net 18.4B USD -2.89%
Operating Lease, Right-of-Use Asset 2.29B USD -21.7%
Intangible Assets, Net (Excluding Goodwill) 55.4B USD -14.6%
Goodwill 68.5B USD +1.1%
Other Assets, Noncurrent 9.82B USD -21.3%
Assets 213B USD -5.79%
Accounts Payable, Current 5.63B USD -16.1%
Employee-related Liabilities, Current 3.84B USD +38.3%
Contract with Customer, Liability, Current 1.51B USD -44%
Liabilities, Current 43B USD -10%
Deferred Income Tax Liabilities, Net 2.12B USD +232%
Operating Lease, Liability, Noncurrent 2.29B USD -12.9%
Other Liabilities, Noncurrent 14.2B USD -14.4%
Liabilities 125B USD -8.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.84B USD +1.5%
Retained Earnings (Accumulated Deficit) 117B USD -1.38%
Stockholders' Equity Attributable to Parent 88.2B USD -0.91%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 88.5B USD -0.89%
Liabilities and Equity 213B USD -5.79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.09B USD -10.1%
Net Cash Provided by (Used in) Financing Activities -4.93B USD -78%
Net Cash Provided by (Used in) Investing Activities 1.73B USD -47.8%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.59B shares +0.32%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.14B USD -222%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.11B USD -62.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415M USD -0.96%
Deferred Tax Assets, Valuation Allowance 1.64B USD -5.75%
Deferred Tax Assets, Gross 19.1B USD +0.39%
Operating Lease, Liability 2.64B USD -16.2%
Payments to Acquire Property, Plant, and Equipment 704M USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8.15B USD +231%
Lessee, Operating Lease, Liability, to be Paid 3.2B USD -16.4%
Property, Plant and Equipment, Gross 34.9B USD -0.31%
Operating Lease, Liability, Current 356M USD -32.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -441M USD +26.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 556M USD -17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.53B USD -5.66%
Additional Paid in Capital 93.6B USD +1.05%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.3B USD
Depreciation, Depletion and Amortization 1.74B USD +16.7%
Deferred Tax Assets, Net of Valuation Allowance 17.5B USD +1.01%
Interest Expense 3.09B USD +39.9%